13F HOLDINGS REPORT
MPM ASSET MANAGEMENT LLC
Quarter ended Q3 2024 · Filed November 13, 2024 · Accession 0000950123-24-011020
Total Value
$145.3M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Entrada Therapeutics, Inc. | TRDA | 4,425,784 | $70.7M | 48.68% |
| 2 | iTeos Therapeutics, Inc. | 46565G104 | 2,738,785 | $28.0M | 19.25% |
| 3 | Dyne Therapeutics, Inc. | DYN | 682,376 | $24.5M | 16.87% |
| 4 | Werewolf Therapeutics, Inc. | HOWL | 4,284,172 | $9.1M | 6.25% |
| 5 | Repare Therapeutics, Inc. | 760273102 | 2,242,636 | $7.7M | 5.31% |
| 6 | Adaptimmune Therapeutics plc | ADTI | 5,555,461 | $5.3M | 3.63% |